Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...
Dave Jackson | June 16, 2021 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. Just a few days after reporting third quarter 2019 earnings, late-stage biotechnology company Iovance Biothe...
Streetwise Reports | November 12, 2019 |

Underground Sampling Extended at Past-Producing Nevada Mine

The mine developer extends its sampling program to include two historical shafts. Goldcliff Resource Corp. (GCN:TSX.V) announced in a news release the results from extended sampling at the past producing Lone Star mine at its Nevada Rand project. Two areas were a...
Streetwise Reports | November 22, 2019 |

Finding the next mineral discoveries using bore water analysis

CSIRO research scientist Dr Nathan Reid taking field measurements on site. Image: CSIRO Powerful technologies and precision instruments are breaking barriers on the path to new resources and metal discoveries By Lynnel Reinson In this current time of volatility,...
Lynnel Reinson | June 12, 2020 |

Buzz on the Bullboards: Whose stocks sizzle during summer holidays?

As we get through the summer holiday season, the typically calmer market environment presents a prime opportunity for investors to evaluate their portfolios and consider new investments. The TSX continues to offer a variety of promising stocks, particularly in energ...
Jonathon Brown | July 4, 2024 |

Should You Buy the Panic?

If anyone has the right to say “I told you so,” it’s Bill Gates. Two years ago, the co-founder, former CEO and now former board member of Microsoft urged governments to step up their preparedness in the event of a modern global ...
Frank Holmes | March 16, 2020 |

How Grooming Genesis for Success may Pay Off

Go big or go home! This corporate battle-cry is proving particularly effective for a select few enterprising Canadian gold explorers that realize the importance of amassing “district-scale” land positions to maximum the prospects of unearthing a ...
Marc Davis | April 29, 2020 |

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations. Revive Therapeutics Ltd. (RVV:TSX.V; RVVTF:OTCMKTS) , a company that focuses on repurposing drugs for infectious diseases and rare disorders, is prepari...
Streetwise Reports | June 4, 2020 |

Not Looking at Gold in Newfoundland? You Should Be

Although it may not get the acclaim of some other areas in Canada - think Yukon or the Abitibi Gold Belt - mining in Newfoundland and Labrador has a rich history going back to the early 1800’s when the province was the sixth biggest copper producer in the world...
Featured Submission | November 12, 2020 |
1 2 3 4